In contrast, levels of circulating CTRP9 were significantly increased patients with T2DM and CAD, suggesting a compensatory response to insulin resistance, inflammatory milieu and endothelial dysfunction (Moradi et al., 2018). This evidence concerns the gene C1QTNF9 and Insulin resistance.